FP6Индивидуална стипендия2006–2008

CANCER GENOME · Genome wide screening for tumour related rearrangements in mouse cancer models

6РП — Действия „Мария Кюри“

Период
2006-03-01 → 2008-02-29
Финансиране от ЕС
167 665 €
Участници
1
Схема
EIF

Линиите свързват координатора с партньорите. За проекти отпреди 2014 г. CORDIS не винаги дава точни координати. Тези точки са на ниво град или държава.

Накратко на български

Генни пренареждания в тумори на мишки без протеина BLOOM помагат да се открият конкретни променени области в ДНК, като например в хромозома 12. Анализът на тези мутации помага да се разбере как се развива ракът при различни видове клетки.

Този кратък обзор е генериран от изкуствен интелект

Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.

Резултати накратко

Final Activity Report Summary - CANCER GENOME (Genome wide screening for tumour related rearrangements in mouse cancer models)

Background Our project aims to perform one of the largest comprehensive analyses of the "cancer genome" in a cancer prone mouse model: irradiated BLOOM deficient mice. Loss of the DNA helicase BLOOM function has been described in human BLOOM syndrome and leads to a breakdown in the maintenance of genome integrity, in particular hyper-recombination and cancer predisposition. Mice deficient for this gene are cancer prone in a wide variety of different cell types including carcinomas, sarcomas and lymphomas. Strategy In order to produce a wide range of tumours of different types, a cohort of 1000 BLOOM deficient mice has been irradiated. Mice were sacrificed when terminally ill and tumours collected In order to identify gene/regions recurrently rearranged, tumour samples were subjected to a complete cytogenetic analysis, including high resolution array CGH (aCGH) and Multicolour FISH (M-FISH). Candidate regions/genes will be tested for their functional significance by single gene knockouts or chromosome engineering. Results -We have harvested thousands of tumour samples from different cell types. -Thirty-too primary cultures, derivated from T lymphoma, have been analysed using high resolution aCGH and M-FISH. These 2 technologies allowed us to find already known candidates cancer region/genes (chromosome 11: Ikaros; Chromosome 15: c-Myc; chromosome 19: Pten), as well as a new region on chromosome 12, which was found to be involved often in translocation, and/or deleted. We were able to identify a 50 kb sub region around 108MB on chromosome 12, within a gene desert, which seemed particularly targeted. We are currently investigating the relevance if this region in cancer using chromosome engineering. -This study is still ongoing and more tumour samples from different cell origins are currently being characterised. Conclusions The BLOOM deficient mice allowed us to harvest hundreds of tumour from different origins generating the tumour panel which is subjected to genetic analysis (aCGH and M-FISH). The strength of M-FISH is in defining translocations and marker chromosomes in complex karyotypes, whereas array CGH can reveal hidden deletions and amplifications. In combination, this promises a very powerful approach to cancer gene discovery.

Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз

Цел на проекта

Cancer in humans is typically a very heterogeneous disease and it is thus difficult to analyse genetically. One of the main thrusts of cancer research over the past 25 years has been to identify genes that are mutated in cancer. The Bradley laboratory is interested in performing one of the largest comprehensive analyses of the and 'cancer genome and in a cancer prone mouse model: irradiated bloom deficient mice. Loss of the DNA helicase Bloom function has been described in human Bloom syndrome and leads to a breakdown in the maintenance of genome integrity, in particular hyper-recombination and cancer predisposition. This gene has been knocked out in mice by the Bradley lab, and like in the human syndrome, bloom deficient mice are cancer prone in a wide variety of different cell types including carcinomas, sarcomas and lymphomas. Thus, this model provides an opportunity to identify genomic regions or genes that are frequently rearranged in cancer. The laboratory has developed an automated method to generate a genome wide molecular profile of a tumour in a single experiment using BAC-CGH arrays (comparative genomic hybridisation). Analysis of tumour DNA extracted from Bloom mouse cancer model will provide information of frequent deleted and amplified region. This study requires the analysis of hundreds of tumours and comparisons of rearrangements from tumours of the same types. Identification of sites of rearrangements will be useful in order to identify new genes involved in cancer. Once identified, these genes could be deleted in mice in order to evaluate their potential function in cancer. This will yield potential new diagnostic opportunities and perhaps might suggest new therapeutic approaches."

Оригинален текст от CORDIS (на английски).

Участници

Връзки

Данни: CORDIS, © Европейски съюз